Publications

Journal Article
Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
Ppublish 62 citations
Open access — free full text available
Open access
Electronic publication date
July 22, 2015

View on Pubmed.gov 25845590 | View on doi.org 10.1093/nar/gkv... (full text)

Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage.

Search for publications in this journal Nucleic Acids Res - 43(8):4202-18

Abstract

Genotoxic stress induces alternative splicing of the oncogene MDM2 generating MDM2-ALT1, an isoform attributed with tumorigenic properties. However, the mechanisms underlying this event remain unclear. Here we explore MDM2 splicing regulation by utilizing a novel minigene that mimics endogenous MDM2 splicing in response to UV and cisplatinum-induced DNA damage. We report that exon 11 is necessary and sufficient for the damage-specific alternative splicing of the MDM2 minigene and that the splicing factor SRSF1 binds exon 11 at evolutionarily conserved sites. Interestingly, mutations disrupting this interaction proved sufficient to abolish the stress-induced alternative splicing of the MDM2 minigene. Furthermore, SRSF1 overexpression promoted exclusion of exon 11, while its siRNA-mediated knockdown prevented the stress-induced alternative splicing of endogenous MDM2. Additionally, we observed elevated SRSF1 levels under stress and in tumors correlating with the expression of MDM2-ALT1. Notably, we demonstrate that MDM2-ALT1 splicing can be blocked by targeting SRSF1 sites on exon 11 using antisense oligonucleotides. These results present conclusive evidence supporting a negative role for SRSF1 in MDM2 alternative splicing. Importantly, we define for the first time, a clear-cut mechanism for the regulation of damage-induced MDM2 splicing and present potential strategies for manipulating MDM2 expression via splicing modulation.

References

Nucleic Acids Res. 2012 Jan;40(1):428-37

Eur J Immunol. 1999 Mar;29(3):823-37

Nat Rev Genet. 2011 Oct;12(10):715-29

Front Physiol. 2012 Mar 28;3:54

Cited by 62 citations (total)

Journal Article

A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation.

Electronic publication date September 6, 2023

Search for publications in this journal J Exp Clin Cancer Res

Xi Chen [...] Yang Zhao et al.

BACKGROUND

Most of the endometrial cancer (EC) patients are diagnosis in early stage with a good prognosis while the patients with...

Journal Article

SRSF10 Connects DNA Damage to the Alternative Splicing of Transcripts Encoding Apoptosis, Cell-Cycle Control, and DNA Repair Factors.

Electronic publication date November 29, 2017

Search for publications in this journal Cell Rep

Lulzim Shkreta [...] Benoit Chabot et al.

RNA binding proteins and signaling components control the production of pro-death and pro-survival splice variants of Bcl-x. DNA damage promoted...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances

Copyright

© The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research.